Quadrant Capital Group’s CVRx CVRX Stock Holding History

Quadrant Capital Group’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-95	Closed	-$1.16K	–	1651
2025 Q1	$1.16K	Buy	+95	New	+$1.34K	﹤0.01%	2585

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quadrant Capital Group's CVRX Position: Q2 2025 in Review

Quadrant Capital Group sold out of CVRx (CVRX) in Q2 2025, closing a stake of 95 shares — an estimated $1.16K sold.

Quadrant Capital Group first reported a position in CVRX in Q1 2025 and held it in 1 quarter. The position peaked at $1.16K in Q1 2025. 92 funds tracked by Wall St. Rank hold CVRX as of Q2 2025.

Quadrant Capital Group reported no remaining CVRx position as of Q2 2025 after selling out during the quarter.
Quadrant Capital Group sold 95 CVRx shares in Q2 2025, an estimated $1.16K.
Quadrant Capital Group first reported a position in CVRx in Q1 2025 and held it in 1 quarter.
Quadrant Capital Group's CVRx position peaked at $1.16K in Q1 2025.
92 funds tracked by Wall St. Rank held CVRx as of Q2 2025.

Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.